-
1 Comment
From a valuation standpoint, the stock is 94.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 70.4.
Based on the above factors, Guided Therapeutics, Inc gets an overall score of 1/5.
| ISIN | None |
|---|---|
| Exchange | OTCQB |
| CurrencyCode | USD |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | 9M |
|---|---|
| PE Ratio | None |
| Beta | 0.41 |
| Target Price | 0 |
| Dividend Yield | None |
Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GTHP using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
